Aurobindo Pharmaceuticals Limited et al v. Daiici Sankyo, Inc. et al
| Aurobindo Pharmaceuticals Limited and Aurobindo Pharma, Inc. |
| Daiici Sankyo, Inc. and Daiichi Sankyo Co., Ltd., |
| Mylan Pharmaceuticals Inc. |
| Alembic Pharmaceuticals limited |
| 1:2016cv04876 |
| May 2, 2016 |
| US District Court for the Northern District of Illinois |
| Chicago Office |
| Cook |
| Rebecca R. Pallmeyer |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
69
MEMORANDUM Opinion and Order: The court grants Defendants' motions to dismiss ( 30 , Alembic, No. 16 C 3956 43 , Aurobindo, No. 16 C 4876 29 ) for lack of personal jurisdiction. The court is aware that Mylan has also intervened as a defenda nt in this case. Plaintiffs, however, have only asserted claims against Daiichi, and the court has concluded that it lacks jurisdiction to hear such claims. Thus the parties are ordered to show cause within 14 days why their cases should not be dismissed in entirety without prejudice. Signed by the Honorable Rebecca R. Pallmeyer on 7/25/2016. Mailed notice. (etv, )
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
